Pesquisas alternativas:
drug dealer » drug dealers (Expandir a Pesquisa), drug dealing (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
drug dealer » drug dealers (Expandir a Pesquisa), drug dealing (Expandir a Pesquisa)
novel ther » novel ether (Expandir a Pesquisa), novel thr (Expandir a Pesquisa), novel theory (Expandir a Pesquisa)
drug does » drug doses (Expandir a Pesquisa), drugs does (Expandir a Pesquisa), drug dose (Expandir a Pesquisa)
drug dev » drug deal (Expandir a Pesquisa), drug diet (Expandir a Pesquisa), drug demo (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
141
Por Rowlinson, Jonathan, Estevez Cebrero, Maria de los Angeles, Lourdusamy, Anbarasu, Rahman, Ruman, Smith, Stuart
Publicado no Neuro Oncol (2018)
“... potential therapeutic targets whose expression is elevated in tumor cells invading brain parenchyma. METHOD...”Publicado no Neuro Oncol (2018)
Obter o texto integral
Obter o texto integral
Artigo
142
Por Pereyra, Carolina Escardó, Silva Júnior, Floriano Paes, Dantas, Rafael Ferreira, Universidade Federal do Rio de Janeiro.
Publicado em 2018
“... uma das maiores causas de morte no mundo. A quimioterapia é um dos pilares no tratamento do câncer...”Publicado em 2018
Obter o texto integral
Livro
143
Por de la Puente, Pilar, Azab, Feda, Muz, Barbara, Luderer, Micah, Arbiser, Jack, Azab, Abdel Kareem
Publicado no Leuk Lymphoma (2015)
“...Despite recent progress in novel and targeted therapies, multiple myeloma (MM) remains a...”Publicado no Leuk Lymphoma (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
144
Por Radoshitzky, Sheli R., Kuhn, Jens H., de Kok-Mercado, Fabian, Jahrling, Peter B., Bavari, Sina
Publicado em 2012
“... therapeutics reported to date, and strategies to identify novel inhibitors for anti-arenaviral therapy. EXPERT...”Publicado em 2012
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
145
Por Rogerio, Kamilla Rodrigues, Boechat, Núbia, Carvalho, Leonardo José de Moura, Aguiar, Lúcia Cruz de Sequeira, Universidade Federal do Rio de Janeiro.
Publicado em 2019
“... common reports of resistance to the drugs used in this therapy. It is therefore important to discover new...”Publicado em 2019
Obter o texto integral
Livro
146
Por Bot, Ilze, Ortiz Zacarías, Natalia V., de Witte, Wilhelmus E. A., de Vries, Henk, van Santbrink, Peter J., van der Velden, Daniël, Kröner, Mara J., van der Berg, Dirk-Jan, Stamos, Dean, de Lange, Elizabeth C. M., Kuiper, Johan, IJzerman, Adriaan P., Heitman, Laura H.
Publicado no Sci Rep (2017)
“..., including atherosclerosis. Several CCR2 antagonists have been developed as potential therapeutic agents...”Publicado no Sci Rep (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
147
Por Gratton, Stephanie E. A., Pohlhaus, Patrick D., Lee, Jin, Guo, Ji, Cho, Moo J., DeSimone, Joseph M.
Publicado em 2007
“...A novel method for the fabrication of polymeric particles on the order of tens of nanometers...”Publicado em 2007
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
148
Por Li, Xin-yang, Zhang, Ting-jian, Kamara, Mohamed Olounfeh, Lu, Guo-qing, Xu, Hai-li, Wang, De-pu, Meng, Fan-hao
Publicado no Cell Death Dis (2019)
“... thymidylate synthase inhibitors that could inhibit cancer cell migration. Therefore, for optimal therapeutic...”Publicado no Cell Death Dis (2019)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
149
Por Salzano, Giuseppina, Navarro, Gemma, Trivedi, Malav S., De Rosa, Giuseppe, Torchilin, Vladimir P.
Publicado no Mol Cancer Ther (2015)
“... novel type of non-toxic and easy-to-obtain nano-device for the combined therapy of siRNA and anti-cancer...”Publicado no Mol Cancer Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
150
Por Ursini, Francesco, Russo, Emilio, De Giorgio, Roberto, De Sarro, Giovambattista, D’Angelo, Salvatore
Publicado no Ther Clin Risk Manag (2018)
“... with the different aspects of the disease, including traditional and biological disease-modifying antirheumatic drugs...”Publicado no Ther Clin Risk Manag (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
151
Por Moraes, Eduardo Cruz, Meirelles, Gabriela Vaz, Honorato, Rodrigo Vargas, de Souza, Tatiana de Arruda Campos Brasil, de Souza, Edmarcia Elisa, Murakami, Mario Tyago, de Oliveira, Paulo Sergio Lopes, Kobarg, Jörg
Publicado no Molecules (2015)
“... division and are considered potential drug targets for the treatment of cancer and other pathologies. We...”Publicado no Molecules (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
152
Por de Oliveira, Ramon Guerra, Guerra, Fabiana Sélos, Mermelstein, Cláudia dos Santos, Fernandes, Patrícia Dias, Bastos, Isadora Tairinne de Sena, Costa, Fanny Nascimento, Barroso, Regina Cely Rodrigues, Ferreira, Fabio Furlan, Fraga, Carlos Alberto Manssour
Publicado no J Enzyme Inhib Med Chem (2018)
“... ROCK inhibitors using the molecular hybridization of the clinically approved drug fasudil (1...”Publicado no J Enzyme Inhib Med Chem (2018)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
153
Por Armas-López, Leonel, Piña-Sánchez, Patricia, Arrieta, Oscar, de Alba, Enrique Guzman, Ortiz-Quintero, Blanca, Santillán-Doherty, Patricio, Christiani, David C., Zúñiga, Joaquín, Ávila-Moreno, Federico
Publicado no Oncotarget (2017)
“... previously been associated with cancer drug resistance, malignant progression and/or clinical prognostic...”Publicado no Oncotarget (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
154
Por Noor Z. Al Dahhan, Fernanda G. De Felice, Fernanda G. De Felice, Fernanda G. De Felice, Douglas P. Munoz, Douglas P. Munoz
Publicado em 2019-03-01
“..., the underlying mechanisms of novel therapeutics on cognition, and to validate preclinical findings of drug...”Publicado em 2019-03-01
Obter o texto integral
Artigo
155
Por Vandamme, Timon, Beyens, Matthias, de Beeck, Ken Op, Dogan, Fadime, van Koetsveld, Peter M, Pauwels, Patrick, Mortier, Geert, Vangestel, Christel, de Herder, Wouter, Van Camp, Guy, Peeters, Marc, Hofland, Leo J
Publicado no Br J Cancer (2016)
Assuntos:
“...Translational Therapeutics...”Publicado no Br J Cancer (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
156
Por Capone, Emily, Giansanti, Francesco, Ponziani, Sara, Lamolinara, Alessia, Iezzi, Manuela, Cimini, Annamaria, Angelucci, Francesco, Sorda, Rossana La, Laurenzi, Vincenzo De, Natali, Pier Giorgio, Ippoliti, Rodolfo, Iacobelli, Stefano, Sala, Gianluca
Publicado no Oncotarget (2017)
“... of this disease sustains an urgent need for more successful, effective drugs. HER-3 - one of the four member...”Publicado no Oncotarget (2017)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
157
Por Raimondi, Lavinia, De Luca, Angela, Morelli, Eugenio, Giavaresi, Gianluca, Tagliaferri, Pierosandro, Tassone, Pierfrancesco, Amodio, Nicola
Publicado no Biomed Res Int (2016)
“..., survival, and drug resistance of tumor cells. MicroRNAs (miRNAs) are short non-coding RNAs that regulate...”Publicado no Biomed Res Int (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
158
Por Lavinia Raimondi, Angela De Luca, Eugenio Morelli, Gianluca Giavaresi, Pierosandro Tagliaferri, Pierfrancesco Tassone, Nicola Amodio
Publicado em 2016-01-01
“..., survival, and drug resistance of tumor cells. MicroRNAs (miRNAs) are short non-coding RNAs that regulate...”Publicado em 2016-01-01
Obter o texto integral
Artigo
159
Por De-Bin Ma, Xing-Yu Liu, Hui Jia, Yingshi Zhang, Qiyu Jiang, Huiwei Sun, Xiaojuan Li, Fang Sun, Yantao Chai, Fan Feng, Lei Liu
Publicado em 2022-05-01
“... mechanism of SREBP-1 regulating the proliferation or drug-resistance in lung squamous cell carcinoma (LUSC...”Publicado em 2022-05-01
Obter o texto integral
Artigo
160
“...With 27 million people affected by Alzheimer’s disease (AD), any proposal of a novel avenue...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo